Vaxart, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period
Vaxart, Inc. (VXRT) reported Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period of 4.64 million shares for the 1-month period ending 2012-10-26, per its 10-K filed 2013-09-27.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod · last filed 2013-09-27
- 2012-10-26: Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 1 month 4.64M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 1 month |
|---|---|
| 2012-10-26 | 4.64M shares 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |